Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma

Abstract

The rise in ctDNA levels observed in patients with UM harboring metastases suggests its potential utility for CNV profiling. These findings highlight the potential of using ctDNA for metastasis detection and patient inclusion in therapeutic studies targeting metastatic UM.